Cargando…
Radiomics and Molecular Classification in Endometrial Cancer (The ROME Study): A Step Forward to a Simplified Precision Medicine
Molecular/genomic profiling is the most accurate method to assess prognosis of endometrial cancer patients. Radiomic profiling allows for the extraction of mineable high-dimensional data from clinical radiological images, thus providing noteworthy information regarding tumor tissues. Interestingly,...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778151/ https://www.ncbi.nlm.nih.gov/pubmed/36553988 http://dx.doi.org/10.3390/healthcare10122464 |
_version_ | 1784856287068028928 |
---|---|
author | Bogani, Giorgio Chiappa, Valentina Lopez, Salvatore Salvatore, Christian Interlenghi, Matteo D’Oria, Ottavia Giannini, Andrea Leone Roberti Maggiore, Umberto Chiarello, Giulia Palladino, Simona Bascio, Ludovica Spano’ Castiglioni, Isabella Raspagliesi, Francesco |
author_facet | Bogani, Giorgio Chiappa, Valentina Lopez, Salvatore Salvatore, Christian Interlenghi, Matteo D’Oria, Ottavia Giannini, Andrea Leone Roberti Maggiore, Umberto Chiarello, Giulia Palladino, Simona Bascio, Ludovica Spano’ Castiglioni, Isabella Raspagliesi, Francesco |
author_sort | Bogani, Giorgio |
collection | PubMed |
description | Molecular/genomic profiling is the most accurate method to assess prognosis of endometrial cancer patients. Radiomic profiling allows for the extraction of mineable high-dimensional data from clinical radiological images, thus providing noteworthy information regarding tumor tissues. Interestingly, the adoption of radiomics shows important results for screening, diagnosis and prognosis, across various radiological systems and oncologic specialties. The central hypothesis of the prospective trial is that combining radiomic features with molecular features might allow for the identification of various classes of risks for endometrial cancer, e.g., predicting unfavorable molecular/genomic profiling. The rationale for the proposed research is that once validated, radiomics applied to ultrasonographic images would be an effective, innovative and inexpensive method for tailoring operative and postoperative treatment modalities in endometrial cancer. Patients with newly diagnosed endometrial cancer will have ultrasonographic evaluation and radiomic analysis of the ultrasonographic images. We will correlate radiomic features with molecular/genomic profiling to classify prognosis. |
format | Online Article Text |
id | pubmed-9778151 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97781512022-12-23 Radiomics and Molecular Classification in Endometrial Cancer (The ROME Study): A Step Forward to a Simplified Precision Medicine Bogani, Giorgio Chiappa, Valentina Lopez, Salvatore Salvatore, Christian Interlenghi, Matteo D’Oria, Ottavia Giannini, Andrea Leone Roberti Maggiore, Umberto Chiarello, Giulia Palladino, Simona Bascio, Ludovica Spano’ Castiglioni, Isabella Raspagliesi, Francesco Healthcare (Basel) Communication Molecular/genomic profiling is the most accurate method to assess prognosis of endometrial cancer patients. Radiomic profiling allows for the extraction of mineable high-dimensional data from clinical radiological images, thus providing noteworthy information regarding tumor tissues. Interestingly, the adoption of radiomics shows important results for screening, diagnosis and prognosis, across various radiological systems and oncologic specialties. The central hypothesis of the prospective trial is that combining radiomic features with molecular features might allow for the identification of various classes of risks for endometrial cancer, e.g., predicting unfavorable molecular/genomic profiling. The rationale for the proposed research is that once validated, radiomics applied to ultrasonographic images would be an effective, innovative and inexpensive method for tailoring operative and postoperative treatment modalities in endometrial cancer. Patients with newly diagnosed endometrial cancer will have ultrasonographic evaluation and radiomic analysis of the ultrasonographic images. We will correlate radiomic features with molecular/genomic profiling to classify prognosis. MDPI 2022-12-07 /pmc/articles/PMC9778151/ /pubmed/36553988 http://dx.doi.org/10.3390/healthcare10122464 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Communication Bogani, Giorgio Chiappa, Valentina Lopez, Salvatore Salvatore, Christian Interlenghi, Matteo D’Oria, Ottavia Giannini, Andrea Leone Roberti Maggiore, Umberto Chiarello, Giulia Palladino, Simona Bascio, Ludovica Spano’ Castiglioni, Isabella Raspagliesi, Francesco Radiomics and Molecular Classification in Endometrial Cancer (The ROME Study): A Step Forward to a Simplified Precision Medicine |
title | Radiomics and Molecular Classification in Endometrial Cancer (The ROME Study): A Step Forward to a Simplified Precision Medicine |
title_full | Radiomics and Molecular Classification in Endometrial Cancer (The ROME Study): A Step Forward to a Simplified Precision Medicine |
title_fullStr | Radiomics and Molecular Classification in Endometrial Cancer (The ROME Study): A Step Forward to a Simplified Precision Medicine |
title_full_unstemmed | Radiomics and Molecular Classification in Endometrial Cancer (The ROME Study): A Step Forward to a Simplified Precision Medicine |
title_short | Radiomics and Molecular Classification in Endometrial Cancer (The ROME Study): A Step Forward to a Simplified Precision Medicine |
title_sort | radiomics and molecular classification in endometrial cancer (the rome study): a step forward to a simplified precision medicine |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778151/ https://www.ncbi.nlm.nih.gov/pubmed/36553988 http://dx.doi.org/10.3390/healthcare10122464 |
work_keys_str_mv | AT boganigiorgio radiomicsandmolecularclassificationinendometrialcancertheromestudyastepforwardtoasimplifiedprecisionmedicine AT chiappavalentina radiomicsandmolecularclassificationinendometrialcancertheromestudyastepforwardtoasimplifiedprecisionmedicine AT lopezsalvatore radiomicsandmolecularclassificationinendometrialcancertheromestudyastepforwardtoasimplifiedprecisionmedicine AT salvatorechristian radiomicsandmolecularclassificationinendometrialcancertheromestudyastepforwardtoasimplifiedprecisionmedicine AT interlenghimatteo radiomicsandmolecularclassificationinendometrialcancertheromestudyastepforwardtoasimplifiedprecisionmedicine AT doriaottavia radiomicsandmolecularclassificationinendometrialcancertheromestudyastepforwardtoasimplifiedprecisionmedicine AT gianniniandrea radiomicsandmolecularclassificationinendometrialcancertheromestudyastepforwardtoasimplifiedprecisionmedicine AT leonerobertimaggioreumberto radiomicsandmolecularclassificationinendometrialcancertheromestudyastepforwardtoasimplifiedprecisionmedicine AT chiarellogiulia radiomicsandmolecularclassificationinendometrialcancertheromestudyastepforwardtoasimplifiedprecisionmedicine AT palladinosimona radiomicsandmolecularclassificationinendometrialcancertheromestudyastepforwardtoasimplifiedprecisionmedicine AT bascioludovicaspano radiomicsandmolecularclassificationinendometrialcancertheromestudyastepforwardtoasimplifiedprecisionmedicine AT castiglioniisabella radiomicsandmolecularclassificationinendometrialcancertheromestudyastepforwardtoasimplifiedprecisionmedicine AT raspagliesifrancesco radiomicsandmolecularclassificationinendometrialcancertheromestudyastepforwardtoasimplifiedprecisionmedicine |